EGFR and large cell neuroendocrine carcinoma: Since we found in the literature [13] a case of large cell neuroendocrine carcinoma of the lung harboring EGFR mutation responding to Gefinitib, EGFR status was evaluated by direct sequencing, resulting wild type.